← Back to Search

Behavioral Intervention

Mind-Body Intervention for Chronic Pain

N/A
Waitlist Available
Led By Michael Donnino, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
1. Adult (≥ 18 years of age)
2. Previously diagnosed with migraine headache based on ICHD-3 beta criteria 91
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4, 8, 13 and 20 weeks
Awards & highlights
No Placebo-Only Group

Summary

The goal of this exploratory study is to test a mind-body interventional approach for the treatment of chronic migraines. The main goal is to obtain feasibility information on the protocol which has been used in other similar conditions. We will also evaluate multiple measurement tools in order to optimize a follow-up pilot study evaluating the impact of the protocol on migraines.

Who is the study for?
This trial is for individuals who frequently experience chronic migraines. Participants should be interested in exploring non-medical treatments and willing to follow the study's mind-body intervention protocol. Specific eligibility details are not provided, but typically include age range, migraine frequency, and overall health status.
What is being tested?
The study is testing a mind-body intervention designed to alleviate chronic migraines. It aims to gather preliminary data on how feasible this approach is based on protocols used for similar conditions and will assess various tools for measuring its effectiveness.
What are the potential side effects?
Since the trial involves a mind-body intervention, traditional medication side effects are not expected. However, participants may experience discomfort or emotional distress related to the practice of these techniques.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4, 8, 13 and 20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4, 8, 13 and 20 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HIT-6
MIDAS
Secondary study objectives
Brief Pain Inventory Questionnaire (Short Form)
Feedback on protocol
GAMS
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mind-Body InterventionExperimental Treatment1 Intervention
A Novel Mind body technique for the intervention will be taught in lectures and group discussion sessions

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
855 Previous Clinical Trials
12,930,951 Total Patients Enrolled
7 Trials studying Chronic Pain
766 Patients Enrolled for Chronic Pain
Michael Donnino, MDPrincipal InvestigatorBeth Israel Deaconess Medical Center
7 Previous Clinical Trials
612 Total Patients Enrolled
2 Trials studying Chronic Pain
185 Patients Enrolled for Chronic Pain
~7 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top